Incannex Healthcare (IXHL) Long-Term Deferred Tax (2020 - 2023)
Incannex Healthcare (IXHL) posted Long-Term Deferred Tax of $4.0 million for Q2 2023, up 18.82% sequentially from $3.4 million in Q2 2022, and up 18.82% YoY from $3.4 million in Q2 2022.
Incannex Healthcare (IXHL) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Incannex Healthcare has reported Long-Term Deferred Tax for 4 years, with the latest figure at $4.0 million in Q2 2023.
- Quarterly Long-Term Deferred Tax rose 18.82% year-over-year to $4.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $4.0 million (up 18.82% YoY) and the FY2023 annual result came in at $4.0 million, up 18.82% from the prior year.
- Long-Term Deferred Tax rose to $4.0 million in Q2 2023 per IXHL's latest filing, from $3.4 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $4.0 million in Q2 2023 and troughed at $1.1 million in Q2 2020.
- A 4-year average of $2.6 million and a median of $2.6 million in 2021 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax surged 90.2% in 2022, then gained 18.82% in 2023.
- Over 4 years, Long-Term Deferred Tax stood at $1.1 million in 2020, then jumped by 55.31% to $1.8 million in 2021, then soared by 90.2% to $3.4 million in 2022, then grew by 18.82% to $4.0 million in 2023.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.0 million, $3.4 million, and $1.8 million for Q2 2023, Q2 2022, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.99 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Jun 30, 2020 | 1.14 Mn |